Palboxen 125 mg (Palbociclib)


Palboxen 125 mg (Palbociclib), generic Ibrance is a prescription medicine used to treat hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in women who have experienced menopause. Palboxen is manufactured by Everest Pharma Ltd. in Bangladesh.

Have to take orally once a day with food for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days.

Side Effects:

The most common adverse reactions are:

Nausea, vomiting, loss of appetite, diarrhea, tiredness, weakness, hair loss, mouth sores, or numbness/tingling of arms/legs.

The above information comes from the Internet. Please consult with doctor for medical advice.

* Any advice on the use of the drug is for reference only. Please consult with the doctor for medical advice. All Names, logos, and trademarks are the property of their respective owners. Watermarks and QR code are used for identification purposes only.


error: Content is protected !!